Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Leerink Partners Analyst
Roanna Ruiz is an analyst at Leerink Partners. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 10/17/2025 | IBIO | Buy Now | iBio | $1.85 | 8.11% | → $2 | Initiates | → Outperform | Get Alert | |
| 08/19/2025 | XERS | Buy Now | Xeris Biopharma Holdings | $7.05 | 27.66% | $7 → $9 | Maintains | Outperform | Get Alert | |
| 06/05/2025 | XERS | Buy Now | Xeris Biopharma Holdings | $7.05 | -0.71% | $6 → $7 | Maintains | Outperform | Get Alert | |
| 04/28/2025 | AKBA | Buy Now | Akebia Therapeutics | $1.61 | 334.78% | → $7 | Initiates | → Outperform | Get Alert | |
| 03/07/2025 | XERS | Buy Now | Xeris Biopharma Holdings | $7.05 | -14.89% | $5 → $6 | Maintains | Outperform | Get Alert | |
| 03/07/2025 | CRMD | Buy Now | Cormedix | $11.41 | 57.81% | → $18 | Initiates | → Outperform | Get Alert | |
| 03/04/2025 | LXRX | Buy Now | Lexicon Pharmaceuticals | $1.21 | -17.36% | → $1 | Downgrade | Outperform → Market Perform | Get Alert | |
| 01/13/2025 | VIR | Buy Now | Vir Biotechnology | $6.69 | 198.92% | $18 → $20 | Maintains | Outperform | Get Alert | |
| 01/13/2025 | SPRY | Buy Now | ARS Pharmaceuticals | $10.59 | 154.96% | $26 → $27 | Maintains | Outperform | Get Alert | |
| 10/25/2024 | AQST | Buy Now | Aquestive Therapeutics | $5.93 | 119.05% | $12 → $13 | Maintains | Outperform | Get Alert | |
| 09/30/2024 | AQST | Buy Now | Aquestive Therapeutics | $5.93 | 102.2% | $10 → $12 | Reiterates | Outperform → Outperform | Get Alert | |
| 09/20/2024 | SPRY | Buy Now | ARS Pharmaceuticals | $10.59 | 136.07% | $21 → $25 | Maintains | Outperform | Get Alert | |
| 05/10/2024 | AQST | Buy Now | Aquestive Therapeutics | $5.93 | 34.8% | → $8 | Initiates | → Outperform | Get Alert | |
| 04/05/2024 | ARDX | Buy Now | Ardelyx | $6.12 | 128.76% | → $14 | Initiates | → Outperform | Get Alert | |
| 03/05/2024 | SPRY | Buy Now | ARS Pharmaceuticals | $10.59 | 69.97% | $6 → $18 | Upgrade | Market Perform → Outperform | Get Alert | |
| 02/05/2024 | UTHR | Buy Now | United Therapeutics | $500.30 | -34.04% | → $330 | Initiates | → Outperform | Get Alert | |
| 08/15/2023 | CYTK | Buy Now | Cytokinetics | $64.34 | -9.85% | → $58 | Initiates | → Outperform | Get Alert | |
| 04/11/2023 | CORT | Buy Now | Corcept Therapeutics | $87.30 | -71.36% | → $25 | Initiates | → Market Perform | Get Alert | |
| 04/04/2023 | PRDS | Buy Now | Pardes Biosciences | — | — | $9 → $2 | Downgrade | Outperform → Market Perform | Get Alert | |
| 02/09/2023 | ENTA | Buy Now | Enanta Pharma | $14.87 | 229.52% | → $49 | Reiterates | → Market Perform | Get Alert | |
| 01/27/2023 | XERS | Buy Now | Xeris Biopharma Holdings | $7.05 | -29.08% | $6 → $5 | Maintains | Outperform | Get Alert | |
| 01/27/2023 | VIR | Buy Now | Vir Biotechnology | $6.69 | 542.68% | $45 → $43 | Maintains | Outperform | Get Alert | |
| 01/27/2023 | SCPH | Buy Now | scPharmaceuticals | — | — | $12 → $13 | Maintains | Outperform | Get Alert | |
| 01/27/2023 | PRDS | Buy Now | Pardes Biosciences | — | — | $12 → $9 | Maintains | Outperform | Get Alert | |
| 01/27/2023 | ENTA | Buy Now | Enanta Pharma | $14.87 | 229.52% | $50 → $49 | Maintains | Market Perform | Get Alert | |
| 01/27/2023 | AVIR | Buy Now | Atea Pharmaceuticals | $3.15 | 90.48% | $8 → $6 | Maintains | Market Perform | Get Alert | |
| 12/20/2022 | NAMS | Buy Now | NewAmsterdam Pharma | $35.35 | -46.25% | → $19 | Initiates | → Outperform | Get Alert | |
| 12/13/2022 | SPRY | Buy Now | ARS Pharmaceuticals | $10.59 | 32.2% | → $14 | Initiates | → Outperform | Get Alert | |
| 11/15/2022 | LNTH | Buy Now | Lantheus Holdings | $66.57 | 80.26% | $110 → $120 | Maintains | Outperform | Get Alert | |
| 11/10/2022 | SCPH | Buy Now | scPharmaceuticals | — | — | $11 → $12 | Maintains | Outperform | Get Alert | |
| 11/04/2022 | VIR | Buy Now | Vir Biotechnology | $6.69 | 572.58% | $40 → $45 | Maintains | Outperform | Get Alert | |
| 11/03/2022 | ALGS | Buy Now | Aligos Therapeutics | $13.40 | -85.07% | $3 → $2 | Maintains | Market Perform | Get Alert | |
| 10/25/2022 | MYOV | Buy Now | Myovant Sciences | — | — | $23 → $27 | Downgrade | Outperform → Market Perform | Get Alert | |
| 10/19/2022 | AMRN | Buy Now | Amarin Corp | $14.65 | -86.35% | $3 → $2 | Maintains | Market Perform | Get Alert | |
| 10/11/2022 | SCPH | Buy Now | scPharmaceuticals | — | — | $6 → $11 | Upgrade | Market Perform → Outperform | Get Alert | |
| 09/14/2022 | VIR | Buy Now | Vir Biotechnology | $6.69 | 497.84% | → $40 | Initiates | → Outperform | Get Alert | |
| 08/16/2022 | PRDS | Buy Now | Pardes Biosciences | — | — | $18 → $12 | Maintains | Outperform | Get Alert | |
| 08/09/2022 | MYOV | Buy Now | Myovant Sciences | — | — | $12 → $23 | Upgrade | Market Perform → Outperform | Get Alert | |
| 08/05/2022 | LNTH | Buy Now | Lantheus Holdings | $66.57 | 65.24% | $100 → $110 | Maintains | Outperform | Get Alert | |
| 08/01/2022 | ENTA | Buy Now | Enanta Pharma | $14.87 | 236.25% | $44 → $50 | Maintains | Market Perform | Get Alert | |
| 07/14/2022 | CFRX | Buy Now | ContraFect | — | — | $9 → $1 | Downgrade | Outperform → Market Perform | Get Alert | |
| 06/06/2022 | LNTH | Buy Now | Lantheus Holdings | $66.57 | 50.22% | → $100 | Assumes | → Outperform | Get Alert | |
| 05/19/2022 | ENTA | Buy Now | Enanta Pharma | $14.87 | 195.9% | $58 → $44 | Maintains | Market Perform | Get Alert | |
| 05/17/2022 | SCPH | Buy Now | scPharmaceuticals | — | — | $5 → $6 | Maintains | Market Perform | Get Alert | |
| 05/10/2022 | ENTA | Buy Now | Enanta Pharma | $14.87 | 290.05% | $68 → $58 | Maintains | Market Perform | Get Alert | |
| 05/05/2022 | ALGS | Buy Now | Aligos Therapeutics | $13.40 | -77.61% | $7 → $3 | Downgrade | Outperform → Market Perform | Get Alert | |
| 05/05/2022 | AMRN | Buy Now | Amarin Corp | $14.65 | -79.52% | $10 → $3 | Downgrade | Outperform → Market Perform | Get Alert | |
| 04/13/2022 | MYOV | Buy Now | Myovant Sciences | — | — | $19 → $12 | Maintains | Market Perform | Get Alert | |
| 03/23/2022 | ALGS | Buy Now | Aligos Therapeutics | $13.40 | -47.76% | $11 → $7 | Maintains | Outperform | Get Alert | |
| 03/15/2022 | PRDS | Buy Now | Pardes Biosciences | — | — | → $18 | Initiates | → Outperform | Get Alert | |
| 03/11/2022 | ALGS | Buy Now | Aligos Therapeutics | $13.40 | -17.91% | $10 → $11 | Maintains | Outperform | Get Alert | |
| 03/01/2022 | AVIR | Buy Now | Atea Pharmaceuticals | $3.15 | 185.71% | $10 → $9 | Maintains | Market Perform | Get Alert | |
| 02/16/2022 | XERS | Buy Now | Xeris Biopharma Holdings | $7.05 | -14.89% | $8 → $6 | Maintains | Outperform | Get Alert | |
| 02/16/2022 | MYOV | Buy Now | Myovant Sciences | — | — | $21 → $19 | Maintains | Market Perform | Get Alert | |
| 02/16/2022 | CFRX | Buy Now | ContraFect | — | — | $14 → $9 | Maintains | Outperform | Get Alert | |
| 02/16/2022 | AVIR | Buy Now | Atea Pharmaceuticals | $3.15 | 217.46% | $11 → $10 | Maintains | Market Perform | Get Alert | |
| 02/16/2022 | AMRN | Buy Now | Amarin Corp | $14.65 | -31.74% | $11 → $10 | Maintains | Outperform | Get Alert | |
| 02/16/2022 | ALGS | Buy Now | Aligos Therapeutics | $13.40 | -25.37% | $15 → $10 | Maintains | Outperform | Get Alert | |
| 02/09/2022 | ENTA | Buy Now | Enanta Pharma | $14.87 | 357.3% | $80 → $68 | Maintains | Market Perform | Get Alert | |
| 01/31/2022 | AMRN | Buy Now | Amarin Corp | $14.65 | -24.91% | $12 → $11 | Maintains | Outperform | Get Alert | |
| 01/13/2022 | ENTA | Buy Now | Enanta Pharma | $14.87 | 438% | $85 → $80 | Maintains | Market Perform | Get Alert | |
| 01/07/2022 | ALGS | Buy Now | Aligos Therapeutics | $13.40 | 11.94% | $29 → $15 | Maintains | Outperform | Get Alert | |
| 01/05/2022 | MYOV | Buy Now | Myovant Sciences | — | — | $23 → $21 | Maintains | Market Perform | Get Alert | |
| 12/31/2021 | XERS | Buy Now | Xeris Biopharma Holdings | $7.05 | 13.48% | $6 → $8 | Maintains | Outperform | Get Alert | |
| 11/23/2021 | ENTA | Buy Now | Enanta Pharma | $14.87 | 471.62% | $92 → $85 | Maintains | Market Perform | Get Alert | |
| 11/18/2021 | AVIR | Buy Now | Atea Pharmaceuticals | $3.15 | 249.21% | → $11 | Downgrade | Outperform → Market Perform | Get Alert | |
| 11/17/2021 | XERS | Buy Now | Xeris Biopharma Holdings | $7.05 | -14.89% | → $6 | Initiates | → Outperform | Get Alert | |
| 11/08/2021 | ENTA | Buy Now | Enanta Pharma | $14.87 | 518.7% | $55 → $92 | Maintains | Market Perform | Get Alert | |
| 10/27/2021 | MYOV | Buy Now | Myovant Sciences | — | — | $24 → $23 | Maintains | Market Perform | Get Alert | |
| 10/20/2021 | AVIR | Buy Now | Atea Pharmaceuticals | $3.15 | 534.92% | $60 → $20 | Maintains | Outperform | Get Alert | |
| 09/09/2021 | AMRN | Buy Now | Amarin Corp | $14.65 | -18.09% | → $12 | Initiates | → Outperform | Get Alert | |
| 09/09/2021 | CFRX | Buy Now | ContraFect | — | — | → $14 | Initiates | → Outperform | Get Alert | |
| 09/09/2021 | ALGS | Buy Now | Aligos Therapeutics | $13.40 | 116.42% | → $29 | Initiates | → Outperform | Get Alert | |
| 09/09/2021 | AVIR | Buy Now | Atea Pharmaceuticals | $3.15 | 1804.76% | → $60 | Initiates | → Outperform | Get Alert | |
| 09/09/2021 | ENTA | Buy Now | Enanta Pharma | $14.87 | 269.87% | → $55 | Initiates | → Market Perform | Get Alert | |
| 09/09/2021 | MYOV | Buy Now | Myovant Sciences | — | — | → $24 | Initiates | → Market Perform | Get Alert | |
| 09/09/2021 | SCPH | Buy Now | scPharmaceuticals | — | — | → $6 | Initiates | → Market Perform | Get Alert | |
| 11/30/2020 | SCPH | Buy Now | scPharmaceuticals | — | — | $11 → $12 | Maintains | Market Perform | Get Alert | |
| 09/28/2020 | AMRN | Buy Now | Amarin Corp | $14.65 | -18.09% | $9 → $12 | Maintains | Outperform | Get Alert | |
| 05/27/2020 | SCPH | Buy Now | scPharmaceuticals | — | — | $12 → $10 | Maintains | Market Perform | Get Alert |
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.